PUBLISHER: The Business Research Company | PRODUCT CODE: 1946593
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946593
Neurology devices are employed for the diagnosis, prevention, and treatment of various neurological disorders, including Alzheimer's, spinal cord injury, traumatic brain injury, and conditions affecting hearing and sight for patients with limb loss or congenital limb differences.
The primary types of neurology devices include cerebrospinal fluid management (CSF) devices and equipment, interventional neurology devices and equipment, neurosurgery devices and equipment, and neurostimulation devices. Neurostimulation devices generate electrical impulses placed under the patient's skin in specific parts of the body. Expenditures for these devices come from both public and private sources. The products encompass Instruments Or Equipment and disposables. Various end-users, including hospitals, clinics, diagnostic laboratories, and others, are involved in the use of neurology devices.
Tariffs are impacting the neurology devices market by increasing costs of imported electronic components, imaging sensors, surgical instruments, and precision manufacturing equipment used across neurostimulation, neurosurgery, and diagnostic devices. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-value medical components, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are raising device prices and extending procurement cycles. However, they are also encouraging localized manufacturing, regional supplier development, and increased investment in domestic medical device innovation.
The neurology devices market research report is one of a series of new reports from The Business Research Company that provides neurology devices market statistics, including neurology devices industry global market size, regional shares, competitors with a neurology devices market share, detailed neurology devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurology devices industry. This neurology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The neurology devices market size has grown rapidly in recent years. It will grow from $20.09 billion in 2025 to $22.44 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising prevalence of neurological disorders, expansion of neurosurgical capabilities in hospitals, increasing availability of advanced imaging technologies, growing demand for minimally invasive procedures, improvements in clinical outcomes of neurology devices.
The neurology devices market size is expected to see rapid growth in the next few years. It will grow to $35.94 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing investments in brain-computer interface research, rising adoption of precision neurology approaches, expansion of outpatient neurology treatment centers, growing demand for non-invasive neurodiagnostic tools, increasing focus on remote neurological monitoring. Major trends in the forecast period include increasing adoption of neurostimulation therapies, rising use of image-guided neurosurgical systems, growing integration of ai in neurological diagnostics, expansion of minimally invasive neurology procedures, enhanced focus on personalized neurological treatments.
Favorable government initiatives are anticipated to drive the expansion of the neurology device market in the coming years. Government initiatives for medical devices include policies, regulations, and programs designed to ensure the safety, quality, and innovation of healthcare products. Such initiatives can boost market growth by shaping regulations, funding research and development, providing financial incentives, expanding telemedicine, raising public health awareness, and enhancing overall healthcare access. For example, in October 2023, the Food and Drug Administration, a US-based federal agency under the Department of Health and Human Services, extended the Total Product Life Cycle Advisory Programme (TAP) to cover neurological and physical medicine devices, with the goal of accelerating technological progress in these fields. By the first quarter of 2025, the FDA intends to add four more offices to the program and enroll up to 65 additional devices. Consequently, supportive government initiatives are fostering the growth of the neurology device market.
Leading companies in the neurology devices market are advancing implantable wireless brain devices, transforming neurological treatment through real-time monitoring and brain-computer interfaces. These innovations emphasize minimally invasive techniques, improved patient outcomes, and personalized therapies. Advanced medical devices are sophisticated tools employing cutting-edge technology for diagnosis, therapy, or monitoring. For instance, in April 2024, Medtronic, an Ireland-based medical device company, introduced the NeuroSmart Portable Micro Electrode Recording (MER) Navigation System. This system enhances Deep Brain Stimulation (DBS) procedures for Parkinson's disease by enabling real-time, precise electrode placement with automatic navigation, resulting in improved patient outcomes and fewer side effects. Its portability and advanced features allow clinicians to deliver tailored treatments efficiently.
In November 2024, Nihon Kohden, a Japan-based provider of high-precision patient monitoring systems and neurological diagnostic equipment, acquired a 71.4% stake in NeuroAdvanced Corp. for an undisclosed sum. With this acquisition, Nihon Kohden intends to strengthen its position in the neurology devices market by combining its established EEG system expertise with Ad-Tech's specialized intracranial electrodes, thereby broadening its capabilities in comprehensive epilepsy diagnostics and neurological care. NeuroAdvanced Corp. is a US-based manufacturer of specialized electrodes for long-term EEG monitoring, brain mapping, SEEG, and brain stimulation.
Major companies operating in the neurology devices market are Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Integra LifeSciences, Abbott Laboratories, LivaNova PLC, Integer, Penumbra Inc., B. Braun Group, Johnson & Johnson, W.L Gore, St. Jude Medical LLC, Parasym, Smiths Medical, Cizeta Surgical, Neuro France Implants, Ectron, Accentus Medical Ltd, Argonaut Therapeutics, Brainwave Discovery, Cerus Endovascular, Chronus Therapeutics, Natus Medical Incorporated, Cerenovus, Nevro, Aleva Neurotherapeutics SA, Cyberonics Inc.
North America was the largest region in the global neurology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the neurology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The neurology devices market consists of sales of neuro thrombectomy devices, carotid artery stents, embolic coils, and support devices that are used to treat neurological disorders. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neurology Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses neurology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for neurology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurology devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.